JNJ

Johnson & Johnson (JNJ)

Healthcare • Drug Manufacturers - General

StockNYSEUnited StatesUS4781601046

285.98 USD +0.87% today Updated 13 Nov 2026 15:28

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Johnson & Johnson, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 15:28. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 26 Jan 2027 in 74 days · 08:00 · estimate 2.92

Last results 2.59 vs 2.52 estimated 13 Oct 2026 · Beat +2.7%

Beat the estimate 9 of 12 0 missed · 3 in line · 2 beats in a row

Average surprise +2.9% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
26 Jan 2027 08:00	2.92	—	—	Upcoming
13 Oct 2026 06:00	2.52	2.59	+2.7%	Beat
15 Jul 2026 06:00	2.85	2.90	+1.6%	Beat
14 Apr 2026 06:00	2.68	2.70	+0.9%	In line
21 Jan 2026 06:00	2.46	2.46	-0.1%	In line
14 Oct 2025 06:00	2.76	2.80	+1.5%	Beat
16 Jul 2025 06:00	2.68	2.77	+3.2%	Beat
15 Apr 2025 06:00	2.58	2.77	+7.4%	Beat
22 Jan 2025 06:00	2.01	2.04	+1.4%	Beat
15 Oct 2024 06:00	2.21	2.42	+9.7%	Beat
17 Jul 2024 06:00	2.70	2.82	+4.3%	Beat
16 Apr 2024 06:00	2.65	2.71	+2.3%	Beat
23 Jan 2024 06:00	2.28	2.29	+0.4%	In line
17 Oct 2023 06:00	2.52	2.66	+5.5%	Beat
20 Jul 2023 06:00	2.62	2.80	+6.9%	Beat
18 Apr 2023 06:00	2.50	2.68	+7.2%	Beat
24 Jan 2023 06:00	2.24	2.35	+5.1%	Beat
18 Oct 2022 06:00	2.49	2.55	+2.6%	Beat
19 Jul 2022 06:00	2.55	2.59	+1.6%	Beat
19 Apr 2022 06:00	2.57	2.67	+4.1%	Beat
25 Jan 2022 06:00	2.12	2.13	+0.5%	In line
19 Oct 2021 06:00	2.35	2.60	+10.5%	Beat
21 Jul 2021 06:00	2.28	2.48	+8.6%	Beat
20 Apr 2021 06:00	2.35	2.59	+10.4%	Beat
26 Jan 2021 06:00	1.83	1.86	+1.8%	Beat
13 Oct 2020 06:00	1.98	2.20	+11.0%	Beat
16 Jul 2020 06:00	1.51	1.67	+10.5%	Beat
14 Apr 2020 07:00	2.00	2.30	+15.2%	Beat
22 Jan 2020 06:00	1.87	1.88	+0.7%	In line
15 Oct 2019 06:00	2.01	2.12	+5.2%	Beat
16 Jul 2019 06:00	2.44	2.58	+5.6%	Beat
16 Apr 2019 06:00	2.04	2.10	+2.8%	Beat
22 Jan 2019 06:00	1.95	1.97	+0.9%	In line
16 Oct 2018 06:00	2.03	2.05	+0.9%	In line
17 Jul 2018 06:00	2.07	2.10	+1.6%	Beat
17 Apr 2018 06:00	2.00	2.06	+2.9%	Beat
23 Jan 2018 06:00	1.72	1.74	+0.9%	In line
17 Oct 2017 06:00	1.80	1.90	+5.4%	Beat
18 Jul 2017 06:00	1.79	1.83	+2.4%	Beat
18 Apr 2017 06:00	1.77	1.83	+3.2%	Beat
24 Jan 2017 06:00	1.56	1.58	+1.0%	Beat
18 Oct 2016 06:00	1.66	1.68	+1.4%	Beat
19 Jul 2016 06:00	1.68	1.74	+3.7%	Beat
19 Apr 2016 06:00	1.65	1.68	+1.8%	Beat
26 Jan 2016 06:00	1.42	1.44	+1.5%	Beat
13 Oct 2015 07:00	1.45	1.49	+2.6%	Beat
14 Jul 2015 07:00	1.68	1.71	+1.7%	Beat
14 Apr 2015 07:00	1.54	1.56	+1.3%	Beat
20 Jan 2015 07:00	1.26	1.27	+1.2%	Beat
14 Oct 2014 07:00	1.45	1.50	+3.7%	Beat

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	94.2B	+6.0%	26.8B	28.5%	11.03	+90.5%	19.3B
2024	88.8B	+4.3%	14.1B	15.8%	5.79	-57.8%	18.1B
2023	85.2B	+6.5%	35.2B	41.3%	13.72	+103.9%	17.8B
2022	80B	—	17.9B	22.4%	6.73	—	17.2B

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by month
Period	Opening price	High	Low	Closing price	Change	Volume	Dividend
Nov 2026 In progress	272.06	286.47	265.28	285.98	+4.68%	72,373,845
Oct 2026	263.68	282.02	245.17	273.20	+3.20%	171,688,700
Sep 2026	270.83	281.07	260.68	264.74	-0.42%	132,305,500
Aug 2026	254.97	276.47	250.44	265.85	+3.71%	136,900,300	1.3400
Jul 2026	253.25	274.90	245.49	256.35	+0.94%	176,660,400
Jun 2026	223.20	259.90	220.84	253.97	+12.71%	188,622,900
May 2026	229.06	235.50	220.37	225.33	-1.97%	154,320,500	1.3400
Apr 2026	245.60	247.21	223.78	229.85	-5.97%	160,246,000
Mar 2026	249.19	251.71	232.24	244.44	-1.61%	170,394,800
Feb 2026	228.32	248.94	227.25	248.43	+9.32%	181,266,300	1.3000
00 Mon 0000	157.29	236.48	315.67	394.86	+0.00%	000,000
00 Mon 0000	553.24	632.43	711.62	790.81	+0.00%	000,000
00 Mon 0000	49.19	128.38	207.57	286.76	+0.00%	000,000
51 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Why Did AAPL, COST, JNJ Stocks Hit 52-Week Highs Today? (opens in a new tab) Stocktwits · 13 Nov 2026 02:32
Johnson & Johnson (JNJ) Backs New Cancer Device And Leads $100 Million Depression Bet (opens in a new tab) Simply Wall St. · 12 Nov 2026 17:11
Johnson & Johnson (JNJ) Up 10.4% Since Last Earnings Report: Can It Continue? (opens in a new tab) Zacks · 12 Nov 2026 15:30
J&J leads Francis Medical investment to fund prostate cancer device (opens in a new tab) MedTech Dive · 12 Nov 2026 15:07
Is There A Risk Hiding In Johnson & Johnson Stock's Earnings? (opens in a new tab) Trefis · 12 Nov 2026 13:00
Johnson & Johnson vs. Procter & Gamble: 64 and 70 Straight Years of Raises. Which Dividend King Pays You More Over the Next Decade? (opens in a new tab) TIKR · 12 Nov 2026 12:51
State Street Health Care SPDR (XLV) Adds Eli Lilly and Johnson & Johnson on Nov. 10 (opens in a new tab) GuruFocus.com · 12 Nov 2026 11:05
Johnson & Johnson vs. Eli Lilly: Which Healthcare Giant's Stock Is a Better Buy for 2027? (opens in a new tab) Motley Fool · 11 Nov 2026 20:20
Johnson & Johnson Sees a Path to Double-Digit Growth by 2030. Is the Dividend King a Buy? (opens in a new tab) Motley Fool · 11 Nov 2026 20:17
J&J funds Francis Medical to seek cancer indication for Vanquish device (opens in a new tab) Medical Device Network · 11 Nov 2026 18:06
Johnson & Johnson Reports Favorable Data For Bipolar Study (opens in a new tab) Benzinga · 11 Nov 2026 17:32
SGOV Yields 3.63%. Can Johnson & Johnson or Verizon Pay Retirees More? (opens in a new tab) 24/7 Wall St. · 11 Nov 2026 15:17
Is Johnson & Johnson (JNJ) Below Fair Value On Cash Flow? (opens in a new tab) Simply Wall St. · 10 Nov 2026 19:11
Johnson & Johnson Says Caplyta Improves Manic Symptoms in Second Phase 3 Study (opens in a new tab) MT Newswires · 10 Nov 2026 15:28
$300,000 in Duke Energy, Philip Morris and Johnson & Johnson: Here’s What It Pays (opens in a new tab) 24/7 Wall St. · 10 Nov 2026 15:17

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 283.52 USD
Market cap: 685.6B
Dividend yield: 1.88%
5-year average yield: 2.67%
Payout ratio: 80%
Last dividend: 1.3400 USD · 24 Nov 2026
Next ex-dividend date: 24 Nov 2026
Exchange: NYSE
Country: United States
Sector: Healthcare
Industry: Drug Manufacturers - General
Currency: USD

Dividends

Ex-dividend date	Per share
25 Aug 2026	1.3400 USD
26 May 2026	1.3400 USD
24 Feb 2026	1.3000 USD
25 Nov 2025	1.3000 USD
00 Mon 0000	394.8600 USD
00 Mon 0000	474.0500 USD
8 older dividends: create a free account to see them

Why this score

Create a free account to see how this score is made Start for free Log in How the score works

Similar shares

Follow JNJ and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in